Generali Asset Management SPA SGR Has $7.38 Million Holdings in Agilent Technologies, Inc. $A

Generali Asset Management SPA SGR grew its position in Agilent Technologies, Inc. (NYSE:A) by 28.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 54,249 shares of the medical research company’s stock after purchasing an additional 11,918 shares during the quarter. Generali Asset Management SPA SGR’s holdings in Agilent Technologies were worth $7,382,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. MGO One Seven LLC grew its holdings in Agilent Technologies by 8.0% in the 4th quarter. MGO One Seven LLC now owns 5,923 shares of the medical research company’s stock valued at $806,000 after buying an additional 439 shares in the last quarter. Cassaday & Co Wealth Management LLC lifted its holdings in shares of Agilent Technologies by 7.2% during the fourth quarter. Cassaday & Co Wealth Management LLC now owns 1,784 shares of the medical research company’s stock worth $243,000 after buying an additional 120 shares in the last quarter. Crestwood Advisors Group LLC lifted its holdings in shares of Agilent Technologies by 32.6% during the fourth quarter. Crestwood Advisors Group LLC now owns 3,882 shares of the medical research company’s stock worth $528,000 after buying an additional 955 shares in the last quarter. Lmcg Investments LLC boosted its position in shares of Agilent Technologies by 5.2% in the fourth quarter. Lmcg Investments LLC now owns 87,194 shares of the medical research company’s stock valued at $11,864,000 after acquiring an additional 4,289 shares during the period. Finally, Praxis Investment Management Inc. grew its stake in shares of Agilent Technologies by 27.3% in the fourth quarter. Praxis Investment Management Inc. now owns 8,793 shares of the medical research company’s stock valued at $1,196,000 after acquiring an additional 1,884 shares in the last quarter.

Agilent Technologies Trading Down 2.6%

Shares of Agilent Technologies stock opened at $115.52 on Friday. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. Agilent Technologies, Inc. has a 12-month low of $106.79 and a 12-month high of $160.27. The company has a market capitalization of $32.65 billion, a price-to-earnings ratio of 25.50, a PEG ratio of 2.50 and a beta of 1.22. The firm’s 50-day moving average price is $115.99 and its two-hundred day moving average price is $131.97.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same quarter in the previous year, the firm posted $1.31 earnings per share. Agilent Technologies’s quarterly revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st were paid a dividend of $0.255 per share. The ex-dividend date was Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s dividend payout ratio is presently 22.52%.

Wall Street Analyst Weigh In

A has been the topic of a number of recent research reports. Wells Fargo & Company lowered their price target on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. UBS Group decreased their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. HSBC began coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price on the stock. Morgan Stanley cut their price target on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, March 3rd. Finally, Barclays reduced their price target on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $163.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.